Guest Contributor


Organizations:
Cytognomix, National Cancer Institute, Ontario Genomics Institute, Pre-commercialization Business Development Fund, and Shannon Human Splicing Pipeline

OGI-backed Cytognomix sells splicing pipeline

Guest Contributor
May 9, 2013

London ON-based Cytognomix has sold its Shannon Human Splicing Pipeline to the US National Cancer Institute (NCI). Cytognomix received early-stage support from the Ontario Genomics Institute through its Pre-commercialization Business Development Fund. The Shannon Pipeline is being used by the NCI to evaluate somatic and germline variants observed in tumor genome next-generation sequences for their potential effects on splicing and resolve significant data interpretation issues in cancer research....


Other News

Canada-Israel energy S&T program launched

SRC adds QEMSCAN service to suite of mining facilities

Network-enabled platforms competitions launched

Genomics bioinformatics receive $11 million






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.